openPR Logo
Press release

Occlusion Devices Market Overview, Cost Structure Analysis of Top Manufacturer, Share, Trend and Forecast To 2023

09-12-2018 09:25 AM CET | Health & Medicine

Press release from: Market Research Future

Occlusion Devices Market Overview, Cost Structure Analysis

MarketResearchFuture.com adds “Occlusion Devices Market– 2018 Global Analysis, Growth, Trends and Opportunities Research Report forecasting to 2023” reports to its database.

Market Highlights:

Occlusion in medical term means the blockage or closing of a blood vessel or hollow organ. There are different occlusion devices used to treat different cardiovascular defects, neurological defects, retinal defects, and others.

The global occlusion devices market is mainly driven by the high prevalence of heart-related diseases and huge demand for diagnosis and treatment methods. Additionally, the increasing availability of diagnostic services for various chronic diseases also fuels the growth of the market. Moreover, favorable reimbursement policies are likely to boost the market growth.
Many private and government insurance organizations are present in developed countries. Over 50 private insurance companies are present in the U.S. The policies cover more than 75% of the cost of the devices and treatment. For instance, under the Medicare Plan in the U.S., if the average cost of the occlusion device is approximately USD 8,000, then USD 6,000 is reimbursed. Additionally, in developed countries such as the U.K., Canada, Germany, and others, similar reimbursement policies are available. On the other hand, alternative treatment methods for chronic diseases and the limited adoption rate may hamper the market growth during the forecast period. Global occlusion devices market is expected to grow at a CAGR of 6.1% during the forecast period.

Request Sample Report @ https://www.marketresearchfuture.com/sample_request/5934

Regional Analysis:

The American occlusion devices market is segmented into two regions, namely, North America and South America. North America, being the largest market, is mainly driven by the increasing patient population suffering from chronic diseases, growing investment in healthcare, and increasing geriatric population. Furthermore, the U.S. is the largest market in North America owing to the presence of a large number of market players manufacturing occlusion devices and increasing awareness about risk factors for chronic diseases. Canada is expected to be the fastest growing market which is driven by the overall increasing demand for medical devices with progress in occlusion devices. South America is expected to be the fastest growing market due to technologically advanced devices for diagnosis and increasing demand for treatment options of chronic and rare diseases.
The European occlusion devices market exhibits a positive growth with an increasing emphasis on the diagnosis of chronic diseases and other related diseases. Moreover, Germany and the U.K. are the major contributors to the growth of the market. Additionally, the increasing expenditure in healthcare by major countries in Europe also accelerates the growth of the market.

Asia Pacific is expected to be the fastest growing market whose growth is attributed to the increasing burden of chronic diseases and increasing focus on early diagnosis and treatment of heart diseases. Furthermore, other factors contributing to the growth of the market are lifestyle changes, the influence of western culture among adults, and addiction to smoking. Additionally, the increasing environmental pollution and exposure to harmful chemicals also attribute to the growth of the market.

The Middle Eastern and African market for occlusion devices exhibits a steady rise with an increase in the number of healthcare facilities providing treatment of chronic conditions and the flourishing growth of the medical device sector, especially the devices used in treatment methods. In the African region, the awareness about chronic diseases is increasing, thus fueling the growth of the market.

Key players of Global Occlusion Devices Market:

Abbott Laboratories (U.S.), Acrostak, Angiodynamics, Asahi Intecc, Avinger, Cardinal Health, Cook Group, Edwards Lifesciences, Penumbra, Stryker Corporation, Terumo Corporation, B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Medtronic plc (Ireland), MicroPort Scientific Corporation (China), Meril Life Sciences Pvt. Ltd. (India), Vascular Concepts (India), and Translumina GmbH (Germany), Boston Scientific Corporation (U.S.), Biosensors International Group, Ltd. (Singapore), Kyoto Medical Planning Co. Ltd. (Japan), Elixir Medical Corporation (U.S.), and others.

Get Instant Discount on Customize Report @ https://www.marketresearchfuture.com/check-discount/5934

Market Segmentation:

The global occlusion devices market is segmented on the basis of product, application, and end-user. On the basis of product, the market is segmented into embolization devices, occlusion removal devices, and support devices. The embolization devices market is sub-segmented into liquid embolic agents and tubal occlusion devices. Occlusion removal devices are sub-segmented into balloon occlusion devices, stent retrievers, coil retrievers, and suction and aspiration devices. The support devices market is sub-segmented into microcatheters and guidewires. On the basis of application, the market is segmented into neurology, cardiology, peripheral vascular diseases, urology, oncology, gynecology, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, surgical centers, ambulatory care centers, and others.

BRIEF TOC:

Chapter 1. Report Prologue

Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations

Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment

…CONTINUED

Have a question Ask to Our Experts @ https://www.marketresearchfuture.com/enquiry/5934

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Occlusion Devices Market Overview, Cost Structure Analysis of Top Manufacturer, Share, Trend and Forecast To 2023 here

News-ID: 1235096 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Occlusion

Major Market Shift in Transcatheter Embolization And Occlusion Devices Industry: …
What Is the Forecasted Market Size and Growth Rate for the Transcatheter Embolization And Occlusion Devices Market? The market size of transcatheter embolization and occlusion devices has seen swift expansion in recent years. It is predicted to escalate from $4.76 billion in 2024 to $5.28 billion in 2025, with a compound annual growth rate (CAGR) of 10.9%. The surge during the historic era can be ascribed to the expansion in
Chronic Total Occlusion Devices Market Overcoming Arterial Blockages: Innovation …
Chronic Total Occlusion Devices Market worth $8.22 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Chronic Total Occlusion Devices Market - (By Product Type (Microcatheters, Guidewires, Crossing Devices, Re-Entry Devices, Others), By End-Use (Hospitals & Diagnostic Center, Ambulatory Care Centers (ACC), Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the
Left Appendage Occlusion Device Market Closing the Gap on Stroke Risk: The Left …
Left Appendage Occlusion Device Market Assessment worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Left Appendage Occlusion Device Market- by Brand (Sierra, AtriClip, WaveCrest, Amplatzer Amulet, WATCHMAN, Ultrasept, LAmbre, and LARIAT), Distribution Channel (Hospitals, Ambulatory Surgical Centers, and Heart Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get a free sample
Occlusion Microcatheter Market Size 2024 to 2031.
Market Overview and Report Coverage An occlusion microcatheter is a small, flexible tube used in minimally invasive procedures to navigate through blood vessels and deliver treatment to specific areas, such as occluding blood vessels to stop bleeding or deliver medication. The global occlusion microcatheter market is projected to grow at a compound annual growth rate (CAGR) of 8.10% during the forecasted period. Factors driving the growth of the occlusion
Retinal Vein Occlusion Pipeline Featuring 15+ Companies Expected to Change the P …
"A PPV may also ablate neovascularization that can cause neovascular glaucoma in the anterior segment. Laser pan-retinal photocoagulation (PRP) can be done to treat neovascularization, with the goal of devitalizing some of the retinal tissue to prevent further neovascularization and treat iris neovascularization. There is no evidence at this time supporting prophylactic PRP without neovascularization" The drug is described in detail in the Retinal Vein Occlusion pipeline report, along with its
Retinal Vein Occlusion Market : Information by Type (Branch Retinal Artery Occlu …
Retinal vein occlusion (RVO) causes permanent blindness. It is dominant in the geriatric population. However, it can also be found in people with leukemia, glaucoma, lymphoma, and multiple myeloma. Retinal vein occlusion is broadly categorized into central retinal artery occlusion (CRAO) and branch retinal vein occlusion (BRVO). Glaucoma is another such condition that damages optic nerves and causes retinal vein occlusion, which is becoming another point of concern across